✨

I tried to paint a 💐.. 😄

As a scientist, one should continuously challenge the current dogma by focusing on original research rather than relying on expert knowledge of review articles.
Tumours form without genetic mutations nature.com/articles/d4158…

Vanakkam, everyone! 😊

💫

#WorldDNADay 🧬 👩🏽‍🔬👩🏽‍⚕️

Nikita Mehra Received this free cancer screening camp available at the primary health care centre in TN. Great initiative!

Cancer is notifiable in the following states. The most populous states, including UP, Maharashtra and Bihar, have not made cancer notification mandatory.

In countries with practically no access to newer myeloma therapies, ASCT for multiple myeloma is alive and kicking. Long-term safety and efficacy of ASCT has been clearly demonstrated. I am reminded of a Blood Journal study by Mehmet Samur, Nikhil C. Munshi, MD et al where despite a…

This innovative 'all-in-one' strategy, which combines allogeneic CD7 CAR T-cell therapy with haploidentical HCT without conditioning or GVHD PPx for CD7-expressing acute myeloid and lymphoid leukemias, is promising but also absolutely wild ... nejm.org/doi/full/10.10…

Excellent editorial by Samer Al Hadidi, MD,MS,FACP about use of T-cell redirecting therapy in myeloma precursor conditions.

Tox of talquetamab can be horrendous- my patients recall it long after moving on to diff treatment.

I disagree with studying it in MGUS/SMM

tinyurl.com/4uvs444s

It’s #DNADay 2024 , in other words, time for my annual “Dr. Rosalind Franklin should loom large in this picture” tweet.
#DNADay #DNADay 24 🧬

Brilliant work by my colleague Bernard Maybury. Most MYC/BCL6r lymphomas harbour a single-hit, reciprocal translocation t(3;8) between MYC and BCL6 (pseudo double-hit) and have better outcomes than t(3;8) negative double-hit cases. doi.org/10.1182/blood.…

Kate / Myeloma Amateur Rahul Banerjee, MD, FACP Gurbakhash Kaur Murali Janakiram Alex Alexandropoulos Urvi Shah Thanks Kate for saying this so eloquently! Extremely disturbing to see this take over and over. Critically appraising trials is a vital part of being a good clinician, and we in academia need to foster it rather than shutting it down!

Of 10 patients with relapsed or refractory hematologic cancers who received sequential CAR T-cell infusion followed by allogeneic stem-cell transplantation without GVHD prophylaxis, 6 were alive and disease-free at last follow-up. Read the full article: nej.md/4dqsTQ3

How to get cancer without DNA mutations, challenging dogma: temporary epigenetic changes
nature natureNV
nature.com/articles/s4158…
nature.com/articles/d4158…
just says in flies
Classenlab CNRS 🌍 Université de Montpellier InstituteHumGenetics

as #India embarks on the world's largest election, what shd the incoming govt do to make #India a #science powerhouse? my opinion in today's The Hindu with 5 specific suggestions, incl 🔼r&d budget, to make this happen & to enable ease of doing science in the country.

Dr. Ravi Kannan from the Cachar Cancer Hospital & Research Centre was the chief guest at CMC Vellore (Official)’s Graduation Ceremony for Medical Super Specialty and Fellowship courses today! He spoke about the fork of life and how one road leads to victory and another to fulfilment. youtube.com/live/TRmd1WAZ8… 37:50

Kicking off our two-day Media Fellowship workshop for Reporting on NCDs (Cancer) with insights from Nikita Mehra, Oncologist & Sr Assoc Prof at Cancer Institute (WIA), Chennai, delivering a thorough overview of cancer to a room of 16 journalists from across the country